Royalty Pharma
- | Investor (buy-side or sell-side research)
Royalty Pharma acquires royalties on Phase 2+ biopharmaceutical products. 8 of the 25 world's top-selling medicines are represented in our portfolio of more than 40 royalty streams. We have done the 9 largest royalty deals.
Address
New YorkNY
United States
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}